Evidence map›Paper›PMID 41217477›Full record

ArticleAbdominal radiology (New York)2026

Hongyue Zhao, Zhehao Lyu, Yexin Su, Huiting Zhang, Ziyue Zhang, Peng Xu, Zhongwei Lv, Peng Fu

Abstract read
In one paragraph

Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hongyue Zhao *First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Zhehao Lyu *First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Yexin SuFirst Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Huiting ZhangHarbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
Ziyue ZhangFirst Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Peng XuFirst Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Zhongwei LvShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Peng FuFirst Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China. fupeng0451@163.com.

Funding

Cultivation Project of the Joint Fund, Heilongjiang Provincial Natural Science Foundation PL2024H077National Natural Science Foundation of China 82371994
6 · The paper itself

Abstract

objectiveThe aim of this study was to investigate the diagnostic performance of the 2.5-dimensional (2.5D) ensemble deep learning (DL) model based on

methodsIn this retrospective study, 177 CRC patients who underwent preoperative

resultsThe ProximalPeritumoral-DenseNet201 model (training cohort: AUC = 0.840, accuracy = 0.772, F1-score = 0.714; internal test cohort: AUC = 0.738, accuracy = 0.796, F1-score = 0.645; parameter amount = 18.097 M, inference time = 47.500 ms) and PrimaryLesion-ResNet50 model (training cohort: AUC = 0.746, accuracy = 0.740, F1-score = 0.628; internal test cohort: AUC = 0.733, accuracy = 0.704, F1-score = 0.619; parameter amount = 23.512 M, inference time = 38.200 ms) achieved an optimal balance between performance and computational efficiency. The performance of the Fusion model combined with the ProximalPeritumoral-DenseNet201 model and PrimaryLesion-ResNet50 model was further improved, with an AUC of 0.874, an accuracy of 0.821, and an F1-score of 0.766 in the training cohort. In the internal test cohort, the AUC was 0.824, the accuracy was 0.815, and the F1-score was 0.722. The Fusion model outperformed the Radiomics and Clinical models. Moreover, it showed good clinical utility and calibration.

conclusionThe 2.5D ensemble DL model based on

Indexed as

Colorectal NeoplasmsDeep LearningFluorodeoxyglucose F18Lymphatic MetastasisPositron Emission Tomography Computed TomographyAdultAgedFemaleHumansMaleMiddle AgedNeoplasm InvasivenessPredictive Value of TestsRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18Radiopharmaceuticals2.5-dimensionalColorectal cancerDeep learningLymphovascular invasion

Identifiers

PMID41217477
PMCPMC13061801

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.